Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06330038 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Anesthesia and Non-small Cell Lung Cancer Recurrence

Study acronym: GASTIVA
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of May 1, 2024 to Aug 5, 2024
    • Study sites: 0 to 1
    v3
  2. Study description expanded, about 1 wordv2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
There has been ongoing debate about the relationship between cancer recurrence and anesthetic management. Therefore, the investigators will test the hypothesis that the recurrence free survival (RFS) after curative resection of NSCLC is higher in patient who received total intravenous anesthesia (TIVA) than volatile anesthetics in this multi-center randomized trials.
Trial Details
NCT Number NCT06330038
Lead Sponsor Samsung Medical Center
Collaborators: Seoul National University Hospital, Asan Medical Center, Severance Hospital, Seoul St. Mary's Hospital, Korea University Guro Hospital, DongGuk University, Inha University Hospital, Konkuk University Medical Center, Ewha Womans University, Chungnam National University Hospital, University of Virginia, Memorial Sloan Kettering Cancer Center, Yale University, Mayo Clinic, University of Texas Southwestern Medical Center, University Hospitals Coventry and Warwickshire NHS Trust, Khon Kaen University, King Chulalongkorn Memorial Hospital, The Affiliated Hospital of Qingdao University, Beijing Hospital, All India Institute of Medical Sciences
Conditions
(from sponsor)		 Non-small Cell Lung Cancer, Surgery, Anesthesia
Related terms Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis, Recurrence
Enrollment 5,384 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov